Shopping Cart

Expired activity

Please go to the PowerPak homepage and select a course.

Estimated time to complete

1.5 hours

Activity Description

Pharmacists are poised to expand their roles in asthma management, and there is much evidence indicating that doing so will improve outcomes, especially for patients with severe asthma. However, to do so pharmacists will need education regarding the current state of severe asthma management and emerging targeted biologic therapies. Pharmacists also need education on how to overcome barriers such as low patient confidence and interest in pharmacists as asthma management specialists, low pharmacist confidence in providing higher-level asthma self-management education, and low communication levels between pharmacists and other HCPs.

Activity Faculty

Mary Bridgeman, PharmD, BCPS, BCGP
Clinical Associate Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Internal Medicine Clinical Pharmacist
Robert Wood Johnson University Hospital

Target Audience

This activity has been designed to meet the educational needs of community pharmacists.

Learning Objectives

Upon completion of this activity, learners should be better able to:

1. Review the current state of severe asthma management, including emerging evidence regarding phenotypes and biomarkers, as well as mechanisms of action of approved and upcoming biologic therapies
2. Analyze the role of the pharmacist in severe asthma management and barriers to achieving optimal asthma control in the pharmacy setting
3. Evaluate strategies to increase both medication adherence and patient confidence in pharmacists as asthma management specialists
4. Address the current issues and challenges for managed care in the treatment of severe asthma and formulate a strategy to alleviate these burdens

Accreditation and Credit Designation

Pharmacists:
American Academy of CME, Inc. is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This activity provides 1.5 contact hours (0.15 CEUs) of continuing education credit. ACPE Universal Activity Number (UAN): 0297-0000-17-013-H01-P. Knowledge.

Disclosure Statement

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.

Disclosures are as follows:

Faculty
Mary Bridgeman, PharmD, BCPS, BCGP
No relevant financial relationships with commercial interests.

Reviewer
Edward J. Moylan, RPh
No relevant financial relationships with commercial interests.

Planning Committee
John JD Juchniewicz, MCIS, CHCP, Wendy Gloffke, PhD and Paul J. Miniter, MS
No relevant financial relationships with any commercial interests.

Off-Label/Investigational Use
This monograph describes a variety of biologic medications and inhalers that may be investigational and not approved by the FDA for the management of severe asthma.

Disclaimer

The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.

Method of Participation

There are no fees to participate in the activity.  Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CPE credit for your participation, please complete the post-test (achieving a passing grade of 70% or greater), and program evaluation. Your certificate can be printed immediately. For pharmacists, a statement of credit will be issued through CPE Monitor in 6-8 weeks. Only learners who provided valid NABP e-Profile ID numbers and month and day of birth (MMDD) will be submitted to CPE Monitor for official record of credit.

Hardware/Software Requirements

Please ensure the computer you plan to use meets the following minimum requirements:

• Operating System: Windows 98 or higher & Macintosh 2.2 or higher
• Internet Browser (Mac &/Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
• Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
• Monitor Screen Resolution: 320 x 480 or higher
• Media Viewing Requirements: Adobe Reader, Microsoft Powerpoint, Flash Player & HTML5

Privacy

For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm

Contact

For any questions, please contact: CEServices@academycme.org

Copyright

© 2018. This CPE-certified activity is held as copyrighted © by American Academy of CME, Inc. Through this notice, the Academy grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).